Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Noboru Yamamoto
Comprehensive Screening of Target Molecules by Next-Generation Sequencing in Patients With Malignant Solid Tumors: Guiding Entry Into Phase I Clinical Trials
Molecular Cancer
Cancer Research
Oncology
Molecular Medicine
First-In-Human Phase I Study of an Oral HSP90 Inhibitor, TAS-116, in Patients With Advanced Solid Tumors
Molecular Cancer Therapeutics
Cancer Research
Oncology
MASTER KEY Project: Powering Clinical Development for Rare Cancers Through a Platform Trial
Clinical Pharmacology and Therapeutics
Pharmacology
First‐in‐human Phase I Study of E7090, a Novel Selective FGFR Inhibitor, in Patients With Advanced Solid Tumors
Cancer Science
Cancer Research
Medicine
Oncology
Phase I Study of Nivolumab, an Anti-Pd-1 Antibody, in Patients With Malignant Solid Tumors
Investigational New Drugs
Oncology
Pharmacology
Comparison of Amrubicin and Weekly Cisplatin/Etoposide/Irinotecan in Patients With Relapsed Small-Cell Lung Cancer
Clinical Lung Cancer
Cancer Research
Oncology
Respiratory Medicine
Pulmonary
An Open-Label Feasibility Study of Nintedanib Combined With Docetaxel in Japanese Patients With Locally Advanced or Metastatic Lung Adenocarcinoma After Failure of First-Line Chemotherapy
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
A Phase I Study of BMS-690514 in Japanese Patients With Advanced or Metastatic Solid Tumors
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
O3-14-5Analyses of CD204+ Macrophages in Allogeneic Stem Cell Transplantation for Malignant Lymphoma in Non-Remission
Annals of Oncology
Medicine
Oncology
Hematology
Number of Metastatic Organs Negatively Affects the Treatment Sequence in Patients With EGFR-TKI Failure
Thoracic Cancer
Medicine
Pulmonary
Respiratory Medicine
Oncology
1
2
›
